Sociedad Americana de Hirudoterapia

[Polyfunctionality of destabilase, a lysozyme from a medicinal leech]

Research article published in Bioorganicheskaia khimiia (2008)

Última actualización: March 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Farmacología salivalBaskova I, Zavalova L · Bioorganicheskaia khimiia, 2008

Abstract

Experimental data indicating the polyfunctionality of destabilase, a lysozyme from the salivary gland secretion of the medicinal leech, a unique representative of invertebrate lysozymes, were analyzed. The destabilase combines the properties of endo-s-lysyl-y-glutamyl isopeptidase (D-dimer monomerase), lysozyme, and chitinase and simultaneously is a nonenzymatic antimicrobial agent. The polypeptide sequence of lysozyme destabilase is encoded by a family of three genes (Ds1, Ds2, and Ds3). The ability of the enzyme to hydrolyze endoisopeptide bonds formed by transglutaminases, which are detected in many pathological conditions, including thrombosis, is considered from the viewpoint of its further application in practice.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEnglish AbstractJournal ArticleResearch Support, Non-U.S. Gov'tReview
Indexed MeSH termsAmino Acid SequenceAnimalsEndopeptidasesHirudo medicinalisMolecular Sequence Data

Resumen

Experimental data indicating the polyfunctionality of destabilase, a lysozyme from the salivary gland secretion of the medicinal leech, a unique representative of invertebrate lysozymes, were analyzed.

Por qué esto importa para la hirudoterapia

Advances understanding of leech salivary bioactive compounds and their therapeutic potential.

Citación

[Polyfunctionality of destabilase, a lysozyme from a medicinal leech].

Baskova I, Zavalova L · Bioorganicheskaia khimiia, 2008

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: March 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

[Polyfunctionality of destabilase, a lysozyme from a medicinal leech] | ASH